CollPlant Biotechnologies (CLGN) Long-Term Debt Repayments (2020)
CollPlant Biotechnologies (CLGN) reported Long-Term Debt Repayments of -$24000.0 for Q4 2020, down 300.0% quarter-over-quarter from -$6000.0 in Q1 2020.
CollPlant Biotechnologies (CLGN) Long-Term Debt Repayments (2020) Analysis & Trends
CollPlant Biotechnologies has reported Long-Term Debt Repayments for 1 years, with the latest figure at -$24000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -24,000.00 |
| Dec 31, 2020 | -24,000.00 |
| Mar 31, 2020 | -6,000.00 |
| Mar 31, 2020 | -6,000.00 |